Ahmet Demirkazık

Ankara University — Turkey

Medicine · Health Sciences

14h-index3.4kcitations102works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(14), Cancer Treatment and Pharmacology(12), Lung Cancer Research Studies(9), Cancer Diagnosis and Treatment(8), Cancer Immunotherapy and Biomarkers(7)

Publications100 total

Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study
Journal of Clinical Oncology·2025· 12 citedOpen Access
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group
Clinical Lung Cancer·2025· 2 cited
Paraneoplastic bilateral vocal cord paralysis in a patient with anti-Hu syndrome after receiving nivolumab: Case report and literature review
Journal of Neuroimmunology·2025· 1 cited
Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach
Cancers·2025Open Access
Paraneoplastic Bilateral Vocal Cord Paralysis Induced by Nivolumab: Case Report and Literature Review
SSRN Electronic Journal·2025Open Access
Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors
Immunotherapy·2024· 5 citedOpen Access
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study
Current Medical Research and Opinion·2024· 1 citedOpen Access
Long-term outcomes of intensity-modulated radiotherapy in limited-stage small-cell lung cancer classified according to AJCC 8th tumor node metastasis staging system.
PubMed·2024
Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients
Anti-Cancer Drugs·2023· 11 cited
Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC
Medicine·2022Open Access
Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors
Anti-Cancer Drugs·2022· 7 cited
The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer
Tuberkuloz ve Toraks·2022Open Access
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group
Journal of Cancer Research and Clinical Oncology·2022· 12 citedOpen Access
Impact of antihistamines use on immune checkpoint inhibitors response in advanced cancer patients
Research Square (Research Square)·2022· 1 citedOpen Access
Sorafenib in Radioactive Iodine Refractory Differentiated Thyroid Cancer: A Real-life Data with Long-term Experience
Journal of Ankara University Faculty of Medicine·2022· 1 citedOpen Access
19P Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation
Annals of Oncology·2021Open Access
Seasonal Influenza and Pneumococcal Vaccination Rates Among Patients with Cancer in COVID-19 Pandemic: A Cross-Sectional Study
Journal of Oncological Sciences·2021· 2 citedOpen Access
Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer
Combinatorial Chemistry & High Throughput Screening·2020· 8 cited
Hedefe Yönelik Tedaviler; EGFR
2020
ERCC1 and XRCC1 single nucleotide polymorphisms can guide treatment decision in patients with metastatic non-small cell lung cancer
Medicine Science | International Medical Journal·2020Open Access
page 1 of 5Next →

Frequent Co-authors

Fikri İçlı(27), Hakan Akbulut(24), Güngör Utkan(19), Bülent Yalçın(14), Yüksel Ürün(12), Filiz Çay Şenler(11), Handan Onur(9), Dìlek Dìnçol(8), Mutlu Doğan(8), Elif Berna Köksoy(8), Abdullah Büyükçelik(6), Güngör Utkan(5), Filiz Çay(5), Orhan Şencan(5), Ali Alkan(5), Nurullah Zengin(4), Koray Ceyhan(4), Ali Arıcan(4), Emre Yekedüz(4), Melih Cem Börüban(4)